Abstract
remaining majority of smooth muscle cells via a 'calcium wave' [20, 21] 
Interstitial cells of Cajal in the gastrointestinal and urinary tracts
Experimental evidence using smooth muscle from the gut has strongly suggested that ICC act as both pacemakers and signal transducers for electrical activity [25, 26] [28] , and from physiological studies using neutralizing antibodies directed against the c-kit receptor in gastrointestinal smooth muscle [29, 30] , has shown that ICCs are essential for normal contractility of the muscle. Studies have also implicated abnormal function of ICCs in several diseases such as diabetic gastroparesis [31] , post-operative ileus [32] , Hirschsprungs disease [33] and gastrointestinal dysmotility following repair of gastroschisis in the neonate [34, 35] .
The morphological and functional role of ICs in the urinary tract has also been the subject of interest recently [36, 37] [40] . In a later study using microelectrodes, a direct role for signal initiation by IC was not confirmed and it was considered that IC might instead modulate signalling rather than generate the signals [41] . A recent study on rabbit bladder suggested that ICs could be an important source of PGs involved in the regulation of spontaneous rhythmic contraction of the bladder [42] .
It can be seen that ICs appear essential for smooth muscle contractility in the gastrointestinal tract and probably in the genitourinary tract. ICs have also been identified in other smooth muscle organs such as in the wall of several blood vessels [43, 44] , gall bladder [45, 46] and fallopian tube [47, 48] . ICs, recently called interstitial Cajal-like cells (ICLC), also exist in pancreas [49] , prostate [50] [51] [52] , penis [53] , mammary gland [54] [55] [56] and myocardium [57] [58] [59] [60] .
Are there m-ICLC in myometrium?
The presence of non-smooth muscle cells (possibly m-ICLC) in the myometrium has been documented by a number of authors [7, 61] Fig. 7 .
More recently, the same group showed evidence that oestrogen and progesterone receptors are located in the nuclei of m-ICLC [63] (Fig. 8) 
. The authors concluded by hypothesising that myometrial ICs could act as 'hormonal "sensors", possibly participating in the regulation of human myometrial contractions (via gap junctions and/or by paracrine signalling)'.
A further publication has supported the observation that m-ICLC are c-kit positive [64] .
m-ICLC were again seen to be located mainly on the boundaries of smooth muscle bundles throughout the myometrium and are present in myometrial biopsies taken throughout reproductive life. Also, it was observed that m-ICLC possess connexin 43 in its unphosphorylated form distributed evenly throughout the cell membrane. The strong and specific expression of this form of connexin 43 may be useful in future experiments for the isolation and identification of m-ICLC and the authors postulated that the pattern of staining could represent the presence of connexin 43 hemichannels (see the section 'Emerging concepts').
All these data are summarized in Table 1 . [72, 73] .
The effect of c-kit inhibition on myometrial contractility c-kit is a transmembrane receptor that has been shown to be essential for the development and the maintenance of the IC phenotype in smooth muscle from the gastrointestinal tract

As m-ICLC express c-kit, the next logical step for a number of investigators was to explore the effect of c-kit receptor inhibition on myometrial contractility. A c-kit receptor antagonist called imatinib mesylate (Glivec) [74] has been used to study the effects of c-kit inhibition on the in vitro contractility of myometrium from term pregnant rabbits. Only amplitude and not frequency was affected following the addition of imatinib and this occurred only at the highest dose studied (100 M)
, whereas a dose of 10 M had no effect [75] Elsevier. with physiological saline. In a third study, imatinib decreased the frequency and amplitude of longitudinal but not circular contractions of the mouse uterus [76] .
. This study was repeated with human myometrium obtained from term elective caesarean sections and again only the amplitude and not the frequency was affected (unpublished observation -Hutchings). In contrast, a different study using human myometrium obtained from benign non-pregnant hysterectomy specimens showed that the administration of imatinib led to a reduction in both amplitude and frequency with the eventual abolition of contractions after prolonged exposure (up to 180 min for 2 M imatinib). Spontaneous contractions were restored after 30 min of washing
Fig. 1 Human myometrium. (A) Methylene blue vital staining, before cryofixation (cryosectioning). Note the selective affinity of an m-ICLC for the blue dye. (B) Silver impregnation after fixation and paraffin embedding. A pyriform m-ICLC cell with a very long, moniliform process. Original magnification: 1000ϫ. Reprinted from Ref. [78], with permission from
Data from studies of muscle from other organs have also led to conflicting conclusions. Three studies observed that imatinib leads to a decrease in contractile amplitude in guinea pig [77] and rat [2] detrusor muscle and in human intestine [78] . In another study, the addition of imatinib to smooth muscle from the gastrointestinal tract of mice abolished muscular activity in a dosedependant manner from a concentration of between 9-27 M up to a dose of 81 M. The effect was reversed when the agent was washed from the tissue [79] . [74] ). This raises the possibility that any effect (Fig. 9) , but why this differs from pregnant myometrium is not easy to explain.
seen with these high doses could be as a result of non-specific effects rather than as a consequence of c-kit inhibition. Secondly, the results from the different studies fall into two broad groups. Either only amplitude is decreased at high doses of imatinib or imatinib has effects on both frequency and amplitude and leads to the eventual abolition of contractions. Perhaps these differences could be explained by differences in species or tissue type, but regarding the two human myometrial studies, there are no obvious differences in methodology that could account for the conflicting results. Popescu's team used nonpregnant myometrium
Data from studies of the gastrointestinal tract has suggested that c-kit inhibition has a delayed effect taking up to 48 hrs to abolish electrical 'slow-wave' activity and to disrupt IC networks as imaged by immunohistochemistry [72] . In order to test for a delayed action on myometrium, the effect of a prolonged administration of imatinib of up to 14 days on myometrial contractility has been investigated in a study using pregnant rabbits [4] . However, no effect was observed on gestation at delivery and no difference in myometrial contractility in vitro was observed between treated and control rabbits. In summary, it does not appear that c-kit receptor inhibition has promise as a potential therapeutic target for the clinical manipulation of uterine contractions. Nor can it be used readily as a research tool for the study of myometrial IC function.
Electrophysiology of m-ICLC
The accepted mechanism for the generation of contractile force in the myometrium is through an action potential giving rise to elevated free cytosolic calcium levels [8] [8] (Fig. 10) . Therefore, it is unclear from these contrasting studies as to whether or not isolated m-ICLC are electrically active.
The use of isolated ICs for the study of spontaneous electrical activity may need to be questioned. In an interesting series of experiments using smooth muscle from the guinea pig stomach, it has been shown that isolated cells that are not spontaneously electrically active can nevertheless be made to function as electrical pacemakers [80] . For conditions to release molecules involved in cell-cell communication [82] . ATP is the molecule implicated most frequently [83, 84] , and a recent study using myometrial biopsies from elective caesarean sections has shown that extracellular ATP appears crucial for the initiation of contractions and regulation of their frequency [85] 
Where do m-ICLC fit in with a model for the generation of myometrial contractions?
A possible schematic model for the generation of myometrial contractions is presented in Fig. 11 . The anatomical arrangement of [81] . This calcium wave would also be consistent with the second slower phase in the biphasic theory.
Future research directions
The model proposed in the previous section fits with existing data regarding tissue-level signalling, but evidently many gaps 
